Neratinib Completed Phase 1 Trials for Advanced Malignant Solid Tumors Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01128842A Study Of Neratinib (HKI-272) And Capecitabine In Japanese With Solid Tumor
NCT00768469Study Evaluating Safety And Tolerability, Solid Tumor
NCT00958724Study Evaluating Neratinib In Combination With Vinorelbine In Subjects With Advanced Or Metastatic Solid Tumors